BOSTON, Massachusetts, August 11, 2025 – Today, S2N Health, Inc. announced that Philadelphia-based Rittenhouse Ventures has completed an investment in S2N Health, joining current investors Excelerate Health Ventures, Boston Millennia Partners and Robin Hood Ventures in fueling the company’s rapid growth in the MedTech commercial intelligence segment. Rittenhouse Partner Sushma Rajagopalan has joined the S2N Health Board of Directors.
“S2N Health exemplifies the kind of AI-powered innovation that aligns perfectly with our investment thesis — digital & data solutions that deliver measurable efficiency and better outcomes for customers,” says Sushma Rajagopalan, Partner at Rittenhouse Ventures. “We’re excited to back their mission to deliver smarter, faster decision-making to MedTech commercial teams, a critical need in today’s high-pressure market environment.”
This investment reflects the strong momentum of S2N Health’s end-to-end commercial intelligence solutions for MedTech, including the RepSignal® platform that natively integrates precision customer insights into Salesforce CRM. S2N Health uniquely leverages deep industry expertise, robust multi-sourced data, advanced analytics and AI to unlock efficient sales growth and align organizations across sales, marketing, and business leadership.
“Rittenhouse Ventures is a terrific partner for our next phase of growth in MedTech and beyond,” says Amy Siegel, Co-Founder and Chief Executive Officer of S2N Health. “We are thrilled to welcome Sushma Rajagopalan, who adds a wealth of experience – both as an investor and a CEO in the global digital technology solutions industry, to our Board of Directors.”
With this additional investment, S2N Health plans to expand its reach in MedTech and advance its roadmap of AI-powered solutions, having recently expanded its partnership with Salesforce to include development on Agentforce, Salesforce’s AI platform, to bring agentic solutions to the future of MedTech sales.
About S2N Health
Founded in 2011, S2N Health accelerates MedTech sales growth and efficiency by delivering robust, actionable commercial intelligence through integrated software and data-enabled services. S2N Health’s RepSignal® platform provides AI-powered customer and market insights, seamlessly integrated in Salesforce CRM, to leading global MedTech companies, empowering field sales and operationalizing growth strategies. For additional information about S2N Health and RepSignal, please visit www.s2nhealth.com.
About Rittenhouse Ventures
Rittenhouse Ventures is an emerging-growth venture capital firm that partners with capital-efficient B2B SaaS, AI and tech-enabled services companies. With a strategic focus on the Mid-Atlantic region and other underserved markets, Rittenhouse invests in companies generating $2M-$10M in revenue, typically into rounds of $5M or less. The firm is dedicated to providing deep operational support and unique network access, collaborating with exceptional management teams to foster sustainable growth and market leadership.